Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis

Abstract Introduction Cancer testis (CT) antigens are attractive targets for cancer immunotherapy because of their expression restriction and immunogenicity. The acrosin binding protein (ACRBP) is a member of CT antigens. This study aimed to evaluate ACRBP expression and immunogenicity in ovarian ca...

Full description

Bibliographic Details

Published in:	Immunity, Inflammation and Disease
Main Authors:	Lina Lin, Weixia Nong, Bin Luo, Yingying Ge, Xia Zeng, Feng Li, Rong Fan, Qingmei Zhang, Xiaoxun Xie
Format:	Article
Language:	English
Published:	Wiley 2021-12-01
Subjects:	ACRBP cancer‑testis antigen diagnostic marker immunotherapy ovarian cancer
Online Access:	https://doi.org/10.1002/iid3.534